Steve Hoffman
Amministratore Delegato presso Tyme, Inc.
Posizioni attive di Steve Hoffman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Tyme, Inc.
 Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Direttore/Membro del Consiglio | 01/07/2013 | - |
| Amministratore Delegato | 01/07/2013 | - |
Storia della carriera di Steve Hoffman
Precedenti posizioni note di Steve Hoffman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TYME TECHNOLOGIES, INC. | Amministratore Delegato | 01/01/2014 | 24/11/2020 |
| Presidente | 01/01/2014 | 21/03/2022 | |
| Direttore Tecnico/Scientifico/R&S | 05/03/2015 | 21/03/2022 | |
| Fondatore | 22/11/2011 | 21/03/2022 | |
| Luminant Biosciences LLC | Amministratore Delegato | 01/03/2015 | 01/10/2020 |
| Direttore Tecnico/Scientifico/R&S | 01/09/2011 | 01/10/2020 | |
| Fondatore | 01/09/2011 | 01/10/2020 | |
Mikronite Technologies Group, Inc.
 Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/1993 | 01/01/2007 |
| Fondatore | 01/01/1993 | 01/01/2007 |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Chief Executive Officer | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
Settori
| Health Technology | 3 |
| Producer Manufacturing | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 4 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
Tyme, Inc.
Tyme, Inc. BiotechnologyHealth Technology Part of Syros Pharmaceuticals, Inc., Tyme, Inc. is a company that provides research and development services focused on developing drug candidates for the treatment of cancer. The company is based in Wilmington, DE. Steve Hoffman has been the CEO of the company since 2013. Tyme was acquired by Tyme Technologies, Inc., part of Syros Pharmaceuticals, Inc. from September 19, 2022 on March 05, 2015. | Health Technology |
Mikronite Technologies Group, Inc.
Mikronite Technologies Group, Inc. Auto Parts: OEMProducer Manufacturing Mikronite Technologies Group, Inc. provides material surfacing technologies. The company was founded by Michael Demurjian and Steve Hoffman and is headquartered in Eatontown, NJ. | Producer Manufacturing |
| Luminant Biosciences LLC |
- Borsa valori
- Insiders
- Steve Hoffman
- Esperienza
